Entering text into the input field will update the search result below

Blonder Tongue Laboratories down 17% on 1H outlook

  • Blonder Tongue Laboratories (BDR -17.2%) reports Q4 EPS of $0.03, but CEO Robert J. Pallé is concerned about 1H'18 outlook and anticipates recovery in 2H.
  • Net revenue $5.57M (+2.2% Y/Y) on increased sales of data products offset in part by a decrease in sales of digital video headend products, analogue video headend products and contract manufactured products; Gross profit $2.23M (+26.09% Y/Y); Net earnings $0.26M (+175.74% Y/Y); Cash burn of $300K in 2017.
  • The company expects "similar Capex in 2018".
  • 10K
  • Transcript

Recommended For You

About BDRL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BDRL--
Blonder Tongue Laboratories, Inc.